Vaccitech’s $110.5 Million Initial Public Offering

Goodwin Procter LLP advised Vaccitech on the deal, while Davis Polk advised the representatives of the several underwriters.Vaccitech (Nasdaq: VACC) announced its initial public offering in…

This content is for members only.
Login to Read More Join Now
Martina Bellini

Author: Martina Bellini

This content is for members only.
Login to Read More Join Now